DUBLIN--(BUSINESS WIRE)--The "Leukemia Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global leukemia therapeutics market to grow with a CAGR of 9.2% over the forecast period of 2018-2024.
Leukemia is the cancer of bone marrow, bone marrow is responsible for the blood cell production and it usually affects the white blood cell or leukocytes. Leukemia is caused when due to over-production of abnormal white blood cells, the part of the immune system which defends the body against infection such as invasion by bacteria, viruses, and fungi, as well as from abnormal cells and other foreign substance. According to WHO, leukemia is the most common blood cancer in males. Furthermore, national cancer institute (NCI) states that the rates of new leukemia cases have been rising on average 0.3% each year over the last 10 years. Death rates have been falling on average 1.0% each year over 2005-2014. Furthermore, in United States around 62,130 people are expected to receive the diagnostic of leukemia in 2017-2018.
The ongoing investments in R&D of leukemia therapeutics and innovation in drug delivery system are the major factors driving the growth of the market worldwide. Rising occurrence of the target disease and high rate of leukemia cases worldwide is anticipating the growth of this market.
Among the geographies, North America is expected to be largest market for leukemia therapeutics followed by Europe due to the technological advancement, increasing patient awareness, and compassionate government policies in terms of incentives and investments in this region.
- Baxter Healthcare
- F. Hoffmann-La Roche
- Bayer HealthCare
- Astex Pharmaceuticals
- Novo Nordisk
Key Topics Covered:
2. Executive Summary
3. Global Leukemia Therapeutics Market Overview
4. Global Leukemia Therapeutics Market by Disease
5. Global Leukemia Therapeutics Market by Region 2018-2024
6. Company Covered
For more information about this report visit https://www.researchandmarkets.com/research/xkjxlp/global_leukemia?w=4